Esomeprazole Sodium Patent Expiration
Esomeprazole Sodium is Used for short-term treatment of gastroesophageal reflux disease (GERD) when oral therapy with Nexium capsules is not possible or appropriate. It was first introduced by Astrazeneca Pharmaceuticals Lp
Esomeprazole Sodium Patents
Given below is the list of patents protecting Esomeprazole Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Nexium Iv |
US5877192 (Pediatric) | Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole |
Nov 27, 2014
(Expired) | Astrazeneca |
| Nexium Iv | US5877192 | Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole |
May 27, 2014
(Expired) | Astrazeneca |
| Nexium Iv | US6143771 | Compounds |
May 27, 2014
(Expired) | Astrazeneca |
Esomeprazole Sodium's Family Patents
Explore Our Curated Drug Screens
Esomeprazole Sodium Generic API Manufacturers
Several generic applications have been filed for Esomeprazole Sodium. The first generic version for Esomeprazole Sodium was by Sun Pharmaceutical Industries Ltd and was approved on Mar 18, 2013. And the latest generic version is by Slate Run Pharmaceuticals Llc and was approved on Feb 10, 2022.
Given below is the list of companies who have filed for Esomeprazole Sodium generic, along with the locations of their manufacturing plants worldwide.
1. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 1 generic for Esomeprazole Sodium. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE/VIAL | injectable | Discontinued | INTRAVENOUS | N/A | Sep 25, 2015 |
2. DEVA HOLDING AS
Deva Holding As has filed for 1 generic for Esomeprazole Sodium. Given below are the details of the strengths of this generic introduced by Deva Holding As.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE/VIAL | injectable | Prescription | INTRAVENOUS | AP | Mar 6, 2017 |
3. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 2 different strengths of generic version for Esomeprazole Sodium. Given below are the details of the strengths of this generic introduced by Eugia Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE/VIAL | injectable | Prescription | INTRAVENOUS | AP | Aug 10, 2016 |
| EQ 20MG BASE/VIAL | injectable | Discontinued | INTRAVENOUS | N/A | Aug 10, 2016 |
Manufacturing Plant Locations New
Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| India |
| |||||||
4. GLAND PHARMA LTD
Gland Pharma Ltd has filed for 2 different strengths of generic version for Esomeprazole Sodium. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE/VIAL
(reference standard) | injectable | Prescription | INTRAVENOUS | N/A | Apr 1, 2020 |
| EQ 40MG BASE/VIAL | injectable | Prescription | INTRAVENOUS | AP | Apr 1, 2020 |
5. MYLAN
Mylan Laboratories Ltd A Viatris Co has filed for 2 different strengths of generic version for Esomeprazole Sodium. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE/VIAL | injectable | Discontinued | INTRAVENOUS | N/A | May 17, 2017 |
| EQ 40MG BASE/VIAL | injectable | Discontinued | INTRAVENOUS | N/A | May 17, 2017 |
Manufacturing Plant Locations New
Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
| India |
| |||||||||||||||||
| Canada |
| |||||||||||||||||
| Ireland |
| |||||||||||||||||
6. SLATE RUN PHARMA
Slate Run Pharmaceuticals Llc has filed for 1 generic for Esomeprazole Sodium. Given below are the details of the strengths of this generic introduced by Slate Run Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 40MG BASE/VIAL
(reference standard) | injectable | Prescription | INTRAVENOUS | AP | Feb 10, 2022 |
7. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Esomeprazole Sodium. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 20MG BASE/VIAL | injectable | Discontinued | INTRAVENOUS | N/A | Mar 18, 2013 |
| EQ 40MG BASE/VIAL | injectable | Discontinued | INTRAVENOUS | N/A | Mar 18, 2013 |
Manufacturing Plant Locations New
Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||||
| India |
| |||||||||||||||||||||||||||||